Millions of men struggle with urinary symptoms caused by an enlarged prostate, or BPH (benign prostatic hyperplasia). Nearly half of all men in their 50s and over 70% of men in their 60s have BPH.1 As the prostate enlarges, it can cause a range of symptoms such as:
While there are surgical treatments and medications available for BPH, they do not work for everyone, and can also cause unwanted side effects, including sexual dysfunction.
If you’re living with symptoms of an enlarged prostate and are interested in exploring treatment options other than drugs or major surgery, you may qualify for the PINNACLE Clinical Trial. The study is for Optilume BPH™, an investigational device designed to relieve BPH symptoms through a minimally-invasive, outpatient procedure.
1. Berry, et al., Journal of Urology 1984
What is Optilume BPH™?
The prostate is about the size of a walnut, and is located at the neck of the bladder. For most men, starting around age 40 their prostate begins to grow, and can grow to the size of an apricot or even a lemon. This enlarged prostate puts pressure on the urethra, the tube that carries urine out of the body. This pressure blocks the natural flow of urine, causing uncomfortable symptoms and irritation.
Optilume BPH is an investigational device designed to relieve the symptoms of BPH through a minimally-invasive, outpatient procedure. The procedure uses a thin, flexible balloon catheter to relieve pressure on the urethra. Then, a specialized medication is delivered to the newly opened space to help maintain symptom relief. The Optilume BPH procedure takes about 15 minutes with patients returning home the same day.
Optilume BPH is currently being offered at select US and Canadian centers through the PINNACLE Clinical Trial. If you qualify and choose to join the trial, you will receive all study-related care and procedures at no cost.
See If You Qualify
To see if you might qualify for the PINNACLE Trial, and to get connected with your local study center to learn more, please take the questionnaire below: